
aiNET is an ETH spin-off based in Basel, Switzerland, offering immunoinformatics services to biopharma and personalized digital immunity solutions to citizens. The company leverages artificial intelligence and large-scale networks to assist pharmaceutical industries and biotechs in discovering biologics from next-generation sequencing data. For citizens, aiNET provides the im2unity app, which helps users check their health, diagnose diseases early, and monitor disease progression to personalize treatment. Their services include analyzing data to select molecules that bind to targets, classifying molecular specificity and affinity, investigating scientific strategies, and humanizing sequences. aiNET aims to provide digital immunity as a service.

aiNET is an ETH spin-off based in Basel, Switzerland, offering immunoinformatics services to biopharma and personalized digital immunity solutions to citizens. The company leverages artificial intelligence and large-scale networks to assist pharmaceutical industries and biotechs in discovering biologics from next-generation sequencing data. For citizens, aiNET provides the im2unity app, which helps users check their health, diagnose diseases early, and monitor disease progression to personalize treatment. Their services include analyzing data to select molecules that bind to targets, classifying molecular specificity and affinity, investigating scientific strategies, and humanizing sequences. aiNET aims to provide digital immunity as a service.